MRSN icon

Mersana Therapeutics

152 hedge funds and large institutions have $590M invested in Mersana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 37 reducing their positions, and 20 closing their positions.

Holders
152
Holders Change
Holders Change %
0%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
20
Increased
68
Reduced
37
Closed
20
Calls
$512K
Puts
$469K
Net Calls
+$43K
Net Calls Change
-$55K
Name Market Value Shares Shares
Change
Shares
Change %
NA
151
NewEdge Advisors
Louisiana
$3 500 +500 New
UOC
152
UBS O'Connor
Illinois
-376,496 Closed
RCAP
153
Resolute Capital Asset Partners
Colorado
-100,000 Closed
SSA
154
Schonfeld Strategic Advisors
New York
-86,151 Closed
Arrowstreet Capital
155
Arrowstreet Capital
Massachusetts
-34,771 Closed
Jane Street
156
Jane Street
New York
-33,416 Closed
E
157
Ergoteles
New York
-32,161 Closed
VF
158
Virtu Financial
New York
-25,521 Closed
AI
159
Atom Investors
Texas
-25,104 Closed
PP
160
PDT Partners
New York
-24,975 Closed
Ensign Peak Advisors
161
Ensign Peak Advisors
Utah
-22,330 Closed
SEI Investments
162
SEI Investments
Pennsylvania
-20,303 Closed
Verition Fund Management
163
Verition Fund Management
Connecticut
-16,312 Closed
PHK
164
Point72 Hong Kong
Hong Kong
-15,156 Closed
CC
165
Cipher Capital
New York
-12,058 Closed
CCIA
166
Campbell & Co Investment Adviser
Maryland
-11,959 Closed
IA
167
IFP Advisors
Florida
-1,800 Closed
Wells Fargo
168
Wells Fargo
California
-1,561 Closed
Group One Trading
169
Group One Trading
Illinois
-742 Closed
S
170
SignatureFD
Georgia
-165 Closed
US Bancorp
171
US Bancorp
Minnesota
-52 Closed
CFGS
172
Concourse Financial Group Securities
Alabama
CAL
173
Capital Advisors Ltd
Ohio
$0 71
RCP
174
Rho Capital Partners
New York
CM
175
Caption Management
Oklahoma